Recludix Pharma Launches with $60 Million Series A to Support Innovative Platform to Discover and Develop Novel SH2 Domain-Targeted Therapies for Cancer and Inflammatory Diseases; Appoints Dr. Nancy Whiting as CEO
European private equity house Montagu has entered exclusive negotiations with Bridgepoint to acquire HTL Biotechnology, a fast-growing biotech and industrial business specialising in pharmaceutical grade biopolymers. The post Bridgepoint sells fast-growing biotech business HTL to Montagu
Buyout giant EQT has agreed to buy into €2.2bn-managing European life science venture capital firm LSP for €450m to strengthen its position in the healthcare sector. A potential earn-out payment of €25m will also be
Ardian and Latour Capital have acquired personal protective equipment (PPE) producer Groupe RG from LBO France.
Private equity house JC Flowers has struck a deal to invest in Tricor Insurance, a US business insurance, employee benefits, personal insurance and individual life and health insurance agency. The post JC Flowers buys into
Healthcare-focused private equity house ArchiMed has secured a majority stake in Cube Biotech, a Germany-based developer of membrane proteins for drug discovery.
Having strengthened its senior team, venture capital firm HealthCap is looking ahead to a busy healthcare and life sciences market, co-managing partners Mårten Steen and Björn Odlander tell Unquote.
GHO Capital Partners, a European healthcare-focused private equity house, has promoted Manuela Rankine to director of sustainable investing.
Aurelius has acquired McKesson UK in a GBP 477m carve-out from its parent company, US-headquartered healthcare and IT company McKesson.
The consumer sector saw healthy amounts of inbound private equity interest in the third quarter of 2021, while more on-trend verticals such as technology and healthcare took a backseat, Unquote Data shows.
